Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic

@article{Pulia2020MultitieredSA,
  title={Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic},
  author={Michael S. Pulia and Terrence P O'brien and Peter C Hou and Andrew Schuman and Robert Sambursky},
  journal={Annals of Medicine},
  year={2020},
  volume={52},
  pages={207 - 214}
}
Abstract Coronavirus disease 2019 (COVID-19), caused by novel enveloped single stranded RNA coronavirus (SARS-CoV-2), is responsible for an ongoing global pandemic. While other countries deployed widespread testing as an early mitigation strategy, the U.S. experienced delays in development and deployment of organism identification assays. As such, there is uncertainty surrounding disease burden and community spread, severely hampering containment efforts. COVID-19 illuminates the need for a… 
Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays
TLDR
High sensitivity and specificity of appropriately validated antibody-based SARS-CoV-2 assays with implications for clinical use and epidemiological seroprevalence studies are demonstrated.
COVID-19: molecular diagnostics overview
TLDR
The molecular overview on the SARS-CoV-2 virus is provided, tremendous efforts that have been made to develop a rapid confirmatory diagnostic test for COVID-19 are summarized and the diagnostic performances of the available tests are analyzed.
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
TLDR
This review covers almost all SARS‐CoV‐2‐related topics extensively to deepen the understanding of the latest achievements and comprehensively review and summarize different aspects of prevention, diagnosis, and treatment of COVID‐19.
The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings
TLDR
The aim of this review paper is to compare the total number and frequencies of SARS-CoV-2 testing in LMICs and high-income countries (HICs) using publicly available data from Worldometer COVID-19, as well as discussing possible interventions and cost-effective measures to increase testing capability in LM ICs.
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic
TLDR
A unified global collaboration must align and coordinate to face the current pandemic and enhance world readiness for future outbreaks based on health equity and equality and review the published facts and findings of CPT’s effectiveness in lowering the mortality rate of COVID-19.
Viral Diagnostics and Preventive Techniques in the Era of COVID-19: Role of Nanoparticles
TLDR
This review primarily provides comprehensive details of the gold standard viral diagnostic methods, with nanoparticles playing a vital role in healthcare platforms, and its mode of action in COVID-19 has been elaborated.
Utility of the FebriDx point‐of‐care test for rapid triage and identification of possible coronavirus disease 2019 (COVID‐19)
TLDR
FebriDx is evaluated, a 10‐minute POC finger‐stick blood test that differentiates viral from bacterial acute respiratory infection through detection of Myxovirus‐resistance protein A (MxA) and C‐reactive protein (CRP) to rapidly isolate viral cases requiring confirmatory testing.
COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
TLDR
Antibiotic stewardship interventions with demonstrated efficacy in mitigating the impact of COVID-19 on ED prescribing should be widely disseminated and inform the ongoing pandemic response.
Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital
TLDR
The goal was to examine the clinical sensitivity of two most common SARS‐CoV‐2 diagnostic test modalities, polymerase chain reaction (PCR) and serology, over the disease course to provide insight into their clinical interpretation in patients presenting to the hospital.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
TLDR
A rapid and simple point‐of‐care lateral flow immunoassay that can detect immunoglobulin M (IgM) and IgG antibodies simultaneously against SARS‐CoV‐2 virus in human blood within 15 minutes which can detect patients at different infection stages is developed.
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
TLDR
This review aims to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies to help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
  • Juanjuan Zhao, Q. Yuan, Zheng Zhang
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients and offer vital clinical information during the course of SARS-CoV-2 infection.
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
TLDR
Combining RNA and antibody detections significantly improved the sensitivity of pathogenic diagnosis for COVID-19 patients (p < 0.001), even in early phase of 1-week since onset (p = 0.007).
Challenges presented by MERS corona virus, and SARS corona virus to global health
  • A. Al-Hazmi
  • Medicine, Biology
    Saudi Journal of Biological Sciences
  • 2016
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan
TLDR
Clinical testing methods for 2019-nCoV require improvement and it is important to treat combined infections and perform rapid screening to avoid cross-contamination of patients.
Supporting the Health Care Workforce During the COVID-19 Global Epidemic.
TLDR
COVID-19 is thought to have higher mortality than seasonal influenza, even as wide variation is reported, and the pressure on the global health care workforce continues to intensify.
Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections
TLDR
FebriDx may help to identify clinically significant immune responses associated with bacterial and viral URIs that are more likely to require clinical management or therapeutic intervention, and has potential to assist with antibiotic stewardship.
A novel coronavirus associated with severe acute respiratory syndrome.
TLDR
A novel coronavirus is associated with this outbreak of severe acute respiratory syndrome, and the evidence indicates that this virus has an etiologic role in SARS.
...
1
2
3
4
5
...